9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      P120-catenin dependent collective brain infiltration by glioma cell networks

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Diffuse brain infiltration by glioma cells causes detrimental disease progression, however its multicellular coordination is poorly understood. We here show that glioma cells infiltrate brain collectively, as multicellular networks. Contacts between moving glioma cells were adaptive epithelial-like or filamentous junctions stabilized by N-cadherin, β-catenin and p120-catenin, which underwent kinetic turn-over, transmitted intercellular calcium transients and mediated directional persistence. Downregulation of p120-catenin compromised cell-cell interaction and communication, disrupted collective networks, and both the cadherin and RhoA binding domains of p120-catenin were required for network formation and migration. Deregulating p120-catenin further prevented diffuse glioma cell infiltration of the mouse brain with marginalized microlesions as outcome. Transcriptomics analysis identified p120-catenin as upstream regulator of neurogenesis and cell cycle pathways and predictor of poor clinical outcome in glioma patients. Collective glioma networks infiltrating the brain thus depend on adherens junctions dynamics the targeting of which may offer an unanticipated strategy to halt glioma progression.

          Related collections

          Most cited references50

          • Record: found
          • Abstract: found
          • Article: not found

          Brain tumour cells interconnect to a functional and resistant network.

          Astrocytic brain tumours, including glioblastomas, are incurable neoplasms characterized by diffusely infiltrative growth. Here we show that many tumour cells in astrocytomas extend ultra-long membrane protrusions, and use these distinct tumour microtubes as routes for brain invasion, proliferation, and to interconnect over long distances. The resulting network allows multicellular communication through microtube-associated gap junctions. When damage to the network occurred, tumour microtubes were used for repair. Moreover, the microtube-connected astrocytoma cells, but not those remaining unconnected throughout tumour progression, were protected from cell death inflicted by radiotherapy. The neuronal growth-associated protein 43 was important for microtube formation and function, and drove microtube-dependent tumour cell invasion, proliferation, interconnection, and radioresistance. Oligodendroglial brain tumours were deficient in this mechanism. In summary, astrocytomas can develop functional multicellular network structures. Disconnection of astrocytoma cells by targeting their tumour microtubes emerges as a new principle to reduce the treatment resistance of this disease.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            WHO 2016 Classification of gliomas.

            Gliomas are the most frequent intrinsic tumours of the central nervous system and encompass two principle subgroups: diffuse gliomas and gliomas showing a more circumscribed growth pattern ('nondiffuse gliomas'). In the revised fourth edition of the WHO Classification of CNS tumours published in 2016, classification of especially diffuse gliomas has fundamentally changed: for the first time, a large subset of these tumours is now defined based on presence/absence of IDH mutation and 1p/19q codeletion. Following this approach, the diagnosis of (anaplastic) oligoastrocytoma can be expected to largely disappear. Furthermore, in the WHO 2016 Classification gliomatosis cerebri is not an entity anymore but is now considered as a growth pattern. The most important changes in the very diverse group of 'nondiffuse' gliomas and neuronal-glial tumours are the introduction of anaplastic pleomorphic xanthoastrocytoma, of diffuse leptomeningeal glioneuronal tumour and of RELA fusion-positive ependymoma as entities. In the last part of this review, after very briefly touching upon classification of neuronal, choroid plexus and pineal region tumours, some practical implications and challenges associated with the WHO 2016 Classification of gliomas are discussed.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Glutamatergic synaptic input to glioma cells drives brain tumour progression

                Bookmark

                Author and article information

                Journal
                100890575
                21417
                Nat Cell Biol
                Nat. Cell Biol.
                Nature cell biology
                1465-7392
                1476-4679
                7 December 2019
                06 January 2020
                January 2020
                06 July 2020
                : 22
                : 1
                : 97-107
                Affiliations
                [1 ]Department of Cell Biology, Radboud University Medical Center, Nijmegen, The Netherlands
                [2 ]Department of Molecular Biology, Radboud University, Nijmegen, The Netherlands
                [3 ]Center for Molecular Medicine, University Medical Center, Utrecht, The Netherlands
                [4 ]Protinhi Therapeutics, Nijmegen, the Netherlands
                [5 ]Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
                [6 ]Cognitive Neuroscience Department, Donders Institute, Radboud University Medical Center, Nijmegen, The Netherlands
                [7 ]Institute of Cell Biology and Neuroscience and BMLS, Goethe University Frankfurt, Germany
                [8 ]Max Planck Institute for Brain Research, Max von Laue Strasse 4, 60438 Frankfurt, Germany
                [9 ]Department of Neurosurgery, VU University Medical Center, Amsterdam, The Netherlands
                [10 ]Department of Biochemistry, Radboud University Medical Center, Nijmegen, The Netherlands
                [11 ]Department of Pathology, Amsterdam University Medical Centers/VUmc and Brain Tumor Center Amsterdam, Amsterdam, The Netherlands
                [12 ]Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
                [13 ]The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
                [14 ]Cancer Genomics Center (Cancergenomics.nl), Utrecht, The Netherlands
                Author notes

                Author contributions

                P.G.G., N.A., C.E.J.D., W.L., P.W., A.A.-P., B.A.W., T.W., H.G.S. and P.F. designed the experiments and interpreted the data. P.G.G., N.A., C.E.J.D., A.C.N., J.-H.V., C.V., B.A.W. and D.S. performed experiments and quantitatively analyzed the data. P.G.G. and P.F. wrote the paper. All authors read and corrected the manuscript.

                Article
                NIHMS1544684
                10.1038/s41556-019-0443-x
                6952556
                31907411
                dcbd01f7-525e-42d8-a5eb-d52720befc0e

                Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms

                History
                Categories
                Article

                Cell biology
                Cell biology

                Comments

                Comment on this article